Needham & Company LLC Forecasts Strong Price Appreciation for Hinge Health (NYSE:HNGE) Stock

Key Points

• Needham & Company LLC has raised its price target for Hinge Health (NYSE:HNGE) from $47.00 to $59.00, indicating a potential upside of 20.93% from the previous close.
• Analysts are bullish on Hinge Health, with 15 "buy" ratings and one "strong buy," while the average target price is $53.07.
• Institutional investors have recently increased their positions in Hinge Health, with notable investments totaling over $1.8 million during the 2nd quarter.

Hinge Health (NYSE:HNGE - Get Free Report) had its price objective hoisted by research analysts at Needham & Company LLC from $47.00 to $59.00 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has a "buy" rating on the stock. Needham & Company LLC's price target would indicate a potential upside of 20.93% from the company's previous close.

HNGE has been the topic of a number of other research reports. Stifel Nicolaus raised their price target on Hinge Health from $48.00 to $55.00 and gave the stock a "buy" rating in a report on Friday, August 1st. KeyCorp raised their price target on Hinge Health from $45.00 to $60.00 and gave the stock an "overweight" rating in a report on Monday, July 14th. Raymond James Financial began coverage on Hinge Health in a report on Monday, June 16th. They set an "outperform" rating and a $45.00 price target on the stock. Evercore ISI began coverage on Hinge Health in a report on Monday, June 16th. They set an "outperform" rating and a $50.00 price target on the stock. Finally, Citigroup began coverage on Hinge Health in a report on Monday, July 14th. They set an "outperform" rating on the stock. One analyst has rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Hinge Health has an average rating of "Buy" and an average target price of $53.07.

Hinge Health Stock Performance

Shares of HNGE stock opened at $48.79 on Wednesday. The business's 50-day moving average price is $43.52. Hinge Health has a 1 year low of $33.42 and a 1 year high of $52.16.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Emerald Advisers LLC acquired a new position in shares of Hinge Health during the 2nd quarter worth approximately $108,000. FNY Investment Advisers LLC acquired a new position in shares of Hinge Health during the 2nd quarter worth approximately $310,000. Strategic Blueprint LLC acquired a new position in Hinge Health in the 2nd quarter valued at $346,000. Finally, CHURCHILL MANAGEMENT Corp acquired a new position in Hinge Health in the 2nd quarter valued at $828,000.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.